("NetScientific" or the "Company" or the "Group")
Change of Adviser
London, UK - 28 July 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic biomedical and healthcare technology group, is pleased to announce the appointment of Stifel Nicolaus Europe Limited as Nominated Adviser and Broker to the Company with immediate effect.
- Ends -
For more information, please contact:
NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO
|
Tel: +44 (0)20 3514 1800 |
Stifel Nicolaus Europe Limited (NOMAD and broker) Jonathan Senior / David Arch / Ben Maddison |
Tel: +44 (0) 20 7710 7600 |
Consilium Strategic Communications Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton |
Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
About NetScientific Plc
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.